Genaera starts trial of Trodusquemine in overweight and obese type ...

Posted in Diabetes obese  on Tue, 02 Dec 2008 08:01:59 -0800

MSI-1436 is a novel therapeutic for the treatment of type 2 diabetes and obesity which works centrally and peripherally to regulate insulin and leptin pathways through the highly selective inhibition of its novel target enzyme, PTP-1B. ...


Original article: Genaera starts trial of Trodusquemine in overweight and obese type ... by at diabetes obese - Google Blog Search



Tags: